<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mu Y</submitter><funding>Specific Research Project of Guangxi for Research Bases and Talents</funding><funding>Science and Technology Major Project of Guangxi</funding><pagination>35011-35019</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9042891</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(55)</volume><pubmed_abstract>Six oxazolomycins (1-6) were isolated from the fermentation broth of a soil-borne bacterial strain, &lt;i>Streptomyces glaucus&lt;/i>. The structures of the new compounds, oxazolomycins D-F (1-3) and glaucumycins A, B (6a/6b), were elucidated by detailed spectroscopic data analysis. Oxazolomycins 1, 2, 4, and 5 demonstrated weak or modest cytotoxic activities against four human cancer cell lines, with IC&lt;sub>50&lt;/sub> values ranging from 10.6 ± 1.7 to 89.5 ± 6.6 μM (or >100 μM). Further study showed that 4 caused S phase cell cycle arrest in SMMC7721 cells through down-regulating the protein expression of cyclin A2, CDK2. Meanwhile, 4 induced apoptosis in SMMC7721 cells through down-regulating the protein levels of Bcl-2, up-regulating the levels of Bax, and activating the cleavage of caspase-3.</pubmed_abstract><journal>RSC advances</journal><pubmed_title>Oxazolomycins produced by &lt;i>Streptomyces glaucus&lt;/i> and their cytotoxic activity.</pubmed_title><pmcid>PMC9042891</pmcid><funding_grant_id>AD18281066</funding_grant_id><funding_grant_id>AA18242026</funding_grant_id><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Li G</pubmed_authors><pubmed_authors>Mu Y</pubmed_authors><pubmed_authors>Han L</pubmed_authors><pubmed_authors>Tan J</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Qu X</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Jiang M</pubmed_authors><pubmed_authors>Li L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Oxazolomycins produced by &lt;i>Streptomyces glaucus&lt;/i> and their cytotoxic activity.</name><description>Six oxazolomycins (1-6) were isolated from the fermentation broth of a soil-borne bacterial strain, &lt;i>Streptomyces glaucus&lt;/i>. The structures of the new compounds, oxazolomycins D-F (1-3) and glaucumycins A, B (6a/6b), were elucidated by detailed spectroscopic data analysis. Oxazolomycins 1, 2, 4, and 5 demonstrated weak or modest cytotoxic activities against four human cancer cell lines, with IC&lt;sub>50&lt;/sub> values ranging from 10.6 ± 1.7 to 89.5 ± 6.6 μM (or >100 μM). Further study showed that 4 caused S phase cell cycle arrest in SMMC7721 cells through down-regulating the protein expression of cyclin A2, CDK2. Meanwhile, 4 induced apoptosis in SMMC7721 cells through down-regulating the protein levels of Bcl-2, up-regulating the levels of Bax, and activating the cleavage of caspase-3.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2026-05-31T23:16:59.13Z</modification><creation>2024-10-17T19:59:26.936Z</creation></dates><accession>S-EPMC9042891</accession><cross_references><pubmed>35494745</pubmed><doi>10.1039/d1ra06182h</doi></cross_references></HashMap>